These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9226785)

  • 1. Economic evaluation in support of national health policy: the case of The Netherlands.
    Elsinga E; Rutten FF
    Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of economic appraisal and health care policy in a health insurance system; the Dutch case.
    Rutten F; van der Linden JW
    Soc Sci Med; 1994 Jun; 38(12):1609-14. PubMed ID: 8047918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of medical technologies in Sweden.
    Jönsson B
    Soc Sci Med; 1997 Aug; 45(4):597-604. PubMed ID: 9226784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of lifestyle interventions in the Netherlands.
    Rappange DR; Brouwer WB
    Health Econ Policy Law; 2012 Apr; 7(2):243-61. PubMed ID: 22380875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of economic appraisal in Denmark.
    Alban A
    Soc Sci Med; 1994 Jun; 38(12):1647-52. PubMed ID: 8047923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of medical technologies: from theory to practice--the German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1997 Aug; 45(4):621-33. PubMed ID: 9226786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom.
    Kanavos P; Trueman P; Bosilevac A
    Int J Technol Assess Health Care; 2000; 16(4):1179-92. PubMed ID: 11155837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and benefits of radiology: a Canadian perspective.
    MacEwan DW; McClarty BM
    Acad Radiol; 1996 Apr; 3 Suppl 1():S88-91. PubMed ID: 8796525
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation of programmes aiming at eradicating infectious diseases.
    Gyldmark M; Alban A
    Health Policy; 1998 Jul; 45(1):69-79. PubMed ID: 10183014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment and economic evaluation: arguments for a national approach.
    Vale L
    Value Health; 2010; 13(6):859-61. PubMed ID: 20701729
    [No Abstract]   [Full Text] [Related]  

  • 18. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies.
    Hailey D
    Soc Sci Med; 1997 Aug; 45(4):563-81. PubMed ID: 9226782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness--limits between optimization and rationing].
    Ruof J; Schöffski O
    Z Rheumatol; 1998 Oct; 57(5):340-4. PubMed ID: 9864843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the Legitimacy of Tough Choices in Healthcare Reimbursement: Approach and Results of a Citizen Forum in The Netherlands.
    Bijlmakers L; Jansen M; Boer B; van Dijk W; Groenewoud S; Zwaap J; Helderman JK; van Exel J; Baltussen R
    Value Health; 2020 Jan; 23(1):32-38. PubMed ID: 31952671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.